Help
Options
Didn't know it?
click below
click below
Knew it?
click below
click below
Don't Know
Remaining cards (0)
Know
retry
shuffle
restart
0:00
Embed Code - If you would like this activity on your web page, copy the script below and paste it into your web page.
Normal Size Small Size show me how
Normal Size Small Size show me how
Hospital Meds
| Term | Definition |
|---|---|
| Acetaminophen; Class Trade Name | -Non narcotic analgesic, antipyretic |
| Acetaminophen; Description Indications | -Elevates the pain threshold in the CNS, and acts on the hypothalamic thermoregulatory centers decreasing temperature -fever and mild to moderate pain |
| Acetaminophen; Contraindications | 1. hypersensitivity 2.hepatitis, hepatic/renal dysfunction 3.alchoholism 4.anemia |
| Acetaminophen; Side effects | - Dizziness, anaphylactic reaction, epidermal reactions, hepatic failure, renal failure, thrombocytopenia, diaphoresis and chills |
| Acetaminophen; Administration Onset /Duration | Adult: 325-650 mg PO q 4-6 hrs, 650 mg PR q 4-6 hrs (max 4g/day) Pediatric: 15 mg/kg q 4-6 hrs (PO or PR) (max 2.6 g/day) -30-60 min, 3-4 hrs |
| Insulin; Class Trade names | -Hormone, Hypoglycemic agent -NPH, Humulin, Novolin, Novolog |
| Insulin; Indications | 1. Diabetic Ketoacidosis 2. Patients with severely high BG levels 3. Hyperkalemia |
| Insulin; Contraindications | 1. Hypoglycemia 2. Caution in hypokalemia |
| Insulin; Side Effects | 1.Allergic reactions 2.Headache 3.Hypoglycemia 4.Hypokalemia |
| Insulin; Administration Onset/Duration | Adult/Peds: 10-25 units SQ. Infuse: 0.1 U/kg/hr IV 30 minutes- 1 hr; 2-3 hrs |
| Meperidine Hydrochloride; Class Trade name | -Opioid Analgesic, CNS depressant, Schedule 2controlled substance -Demerol |
| Meperidine Hydrochloride; Description | Depresses pain perception by acting on the opioid receptor in the CNS |
| Meperidine Hydrochloride; Indication | Moderate to severe pain |
| Meperidine Hydrochloride; Contraindications | Hypersensitivity MAO inhibitors within 2 weeks Head injury Abdominal Pain of unknown etiology Hypovolemia |
| Meperidine Hydrochloride; Side Effects | Headache, CNS depression, Respiratory/Cardiovascular Depression, Dry mouth/nausea/vomiting, Flushing/Uticaria/Diaphoresis/Pruitus, Constipation, QT prolongation, Constipation, Pupil constriction(Miosis) |
| Meperidine Hydrochloride; Administration Onset/Duration | Adult: IV 25-50 mg. IM 50-100 mg Pediatrics: 1 mg/kg 5 min IV, 10 min IM; 2-4 hrs |
| Hydromorphone; Class Trade Name | -Synthetic opioid analgesic, CNS depressant, Schedule 2 controlled substance. - Dilaudid |
| Hydromorphone; Description | Centrally acting analgesic that binds to the opiate receptor sites in the CNS. Suppresses cough via suppression of the medulla. |
| Hydromorphone; Indications | Moderate to severe pain. Antitussive. |
| Hydromorphone; Contraindications | 1. Hypersensitivity 2. Head injury 3. Abdominal pain 4. Hypovolemia |
| Hydromorphone; Side Effects | 1. Headache 2. CNS depression 3. Respiratory/Cardiovascular Depression 4. Dry mouth/nausea/vomiting 5. Flushing/uticaria/diaphoresis/pruritus 6. Constipation 7. QT prolongation 8. Pupil constriction (miosos) |
| Hydromorphone; Administration Onset/Duration | Adult: IV 1 mg followed by .5-1 mg q 3-5 min prn IM 2-4 mgq 3-4 hrs. Pediatrics: not recommended - 2-3 min, 3-6 hrs |
| TDaP: | Tetanus toxoid and reduced Diptheria toxoid and Acellular Pertussis |
| TDap; Class Trade Name | - Vaccine Combo - Adacel, Boostrix, Tdap |
| TDaP; Description | Stimulates active immunity to diphtheria, tetanus, and pertussis toxins due to antibody production following exposure to the weakened toxins in the vaccine. |
| TDaP; Indications | Initial vaccination is recommended for all individuals to prevent infection with tetanus, diphtheria, and pertussis. Boosters are recommended every 5-10 years and with each pregnancy. |
| TDaP; Tetanus (lockjaw) | Enviornmentally prevalent bacterium that produces toxins that lead to severe tonic muscle spasms. Early spasms typically effect jaw, face and neck. Full body spasms cause fractures, muscle/tendon rupture, and death from respiratory paralysis. |
| TDaP; Diphtheria | Highly contagious respiratory infection that causes a thick pseudomembrane to form on the lining of the airway passages. Can cause fatal asphyxiation. |
| TDaP; Pertussis (Whooping Cough) | Highly contagious respiratory infection causing upper respiratory symptoms and severe bronchitis with a severe cough. Can cause fatal respiratory failure. |
| TDaP; Contraindications | 1. Anaphylactic reaction to a prior dose, or any of the components. 2. Encephalopathy within 7 days of a previous dose. |
| TDaP; Side Effects | 1. Swelling, redness, rash and pain at injection site 2. Nausea, vomiting, and diarrhea 3. Fever, Chills, body aches, muscle weakness 4. Headache 5. Seizure |
| TDaP; Administration | 0.5 mL IM (typically in the deltoid) |
Created by:
StudyMonster
Popular Pharmacology sets